We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ATAI Life Sciences NV | NASDAQ:ATAI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.09 | 4.89% | 1.93 | 1.90 | 1.93 | 1.9425 | 1.825 | 1.85 | 875,491 | 00:59:08 |
About ATA Inc.ATA is focused on providing quality educational experiences and services for students throughout China and abroad. ATA aims to offer online, on-campus, and other education programs through a network of global education partners. For more information, please visit ATA’s website at www.atai.net.cn.
Cautionary Note Regarding Forward-looking StatementsThis announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terms such as "believe," "could," "expect," "future," "look forward to," "plan," "should," "will," and similar terms. Examples of forward-looking statements in this press release include statements about ATA’s plans for mergers and acquisitions generally; and ATA’s anticipated acquisition of Beijing Biztour, the anticipated benefits and risks of such acquisition, and subsequent business activities. These forward-looking statements involve known and unknown risks and uncertainties, are based on current expectations, assumptions, estimates, and projections by ATA, and are subject to governmental approvals and other conditions. The Company undertakes no obligation to update forward-looking statements, except as may be required by law. The Company cannot assure you that its expectations and assumptions will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results.
For more information on our company, please contact the following individuals: | ||
At the Company | Investor Relations | |
ATA Inc. | The Equity Group Inc. | |
Amy Tung, Chief Financial Officer | Adam Prior, Senior Vice President | |
+86 10 6518 1122 x5518 | 212-836-9606 | |
amytung@atai.net.cn | aprior@equityny.com | |
Katherine Yao, Senior Associate | ||
+86 10 6587 6435 | ||
kyao@equityny.com |
1 Year ATAI Life Sciences NV Chart |
1 Month ATAI Life Sciences NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions